Huawei building chip facilities in China to evade U.S. sanctions
- August 23, 2023
- Posted by: Quatro Strategies
- Categories: AI & Semiconductors, China, Sanctions & Regulation
Huawei Technologies Co is reportedly establishing secret semiconductor fabrication facilities across China to evade U.S. sanctions, according to the Semiconductor Industry Association, based in Washington. The Chinese tech giant, which entered chip production last year, is believed to be receiving around $30 billion in state funding from the Chinese government for its chip efforts. The association has stated that Huawei has acquired at least two existing plants and is constructing three more.
Due to Huawei’s placement on the U.S. Commerce Department’s export control list in 2019, the company faces restrictions on purchasing American chip-making equipment directly. However, if the company is constructing these facilities under the names of other entities, it could potentially bypass U.S. government restrictions by indirectly acquiring American chip-making equipment.
Huawei has been facing increasing scrutiny and trade restrictions in the United States over concerns about national security. The company has been placed on a trade blacklist, which severely limits its ability to source goods and technology from U.S. suppliers without obtaining special licenses. The U.S. government has tightened controls to prevent Huawei from acquiring or designing the semiconductor chips used in its products.
Neither Huawei nor the Semiconductor Industry Association have provided immediate comments on this report.
Interested in learning more?
Sign up for Top Insights Today
Top Insights Today delivers the latest insights straight to your inbox.
You will get daily industry insights on
Oil & Gas, Rare Earths & Commodities, Mining & Metals, EVs & Battery Technology, ESG & Renewable Energy, AI & Semiconductors, Aerospace & Defense, Sanctions & Regulation, Business & Politics.
Read more insights
Washington’s research cuts undermine the engine of reindustrialization
Since the 1990s, U.S. cities from Cleveland to Raleigh-Durham to Austin have leaned on research universities, teaching hospitals, and federally funded science to counter the collapse of mid-century manufacturing. That mix of steady clinical demand, grant-driven labs, and tech transfer offices that push IP into startups has quietly built America’s modern innovation backbone: biotech and oncology, robotics and AI, medical devices and materials science.
It’s imperfect; universities can feel extractive on tax bases, and prosperity often skips the blocks right outside the campus gates. But thriving metro areas have tethered to a research complex or health system. In Pittsburgh, nearly 200,000 people work in education and health, versus fewer than 7,500 in steel. On the ground, “eds and meds” isn’t a slogan; it’s payroll, procurement, and patient capital.
Global FDI faces challenges amid geopolitical tensions
Foreign direct investment (FDI) is facing headwinds globally, impacted by the geopolitical tensions between the United States and China, rising protectionism, higher interest rates, and slow economic growth. According to the World Bank, FDI fell to 1.7% of global output in 2022, down from…
Red Sea attacks prompt oil market to embrace localized trading patterns
The global oil market is witnessing a notable transformation as a result of militant attacks in the Red Sea and escalating freight rates, leading to a shift towards more localized trading. A significant drop in tanker traffic through the Suez Canal is giving rise to a split in the market, delineating one trading…